|
CA2956163C
(en)
|
2014-07-24 |
2023-01-10 |
W.R. Grace & Co.-Conn. |
Crystalline form of nicotinamide riboside
|
|
ES2963057T3
(es)
*
|
2015-03-09 |
2024-03-25 |
Grace W R & Co |
Forma cristalina de ribósido de nicotinamida
|
|
US9855289B2
(en)
|
2015-08-05 |
2018-01-02 |
Metro International Biotech, Llc |
Nicotinamide mononucleotide derivatives and their uses
|
|
WO2017042198A2
(en)
*
|
2015-09-08 |
2017-03-16 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Agents and methods using thereof for the prevention and treatment of stem cell muscle disorders
|
|
GB2542881B
(en)
|
2015-10-02 |
2020-01-01 |
Carr Andrew |
Crystal forms of ß-nicotinamide mononucleotide
|
|
US10611790B2
(en)
|
2015-11-02 |
2020-04-07 |
Mitobridge, Inc. |
Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases
|
|
CN109562104A
(zh)
*
|
2016-04-14 |
2019-04-02 |
可劳迈戴斯有限公司 |
烟酰胺核苷、烟酸核苷、烟酰胺单核苷酸、和烟碱基化合物衍生物在婴儿配方中的用途
|
|
GB2553001A
(en)
*
|
2016-08-19 |
2018-02-21 |
The Queen's Univ Of Belfast |
Lactone intermediates of nicotinamide riboside and nicotinate riboside
|
|
JP7132907B2
(ja)
|
2016-08-22 |
2022-09-07 |
エリジウム・ヘルス・インコーポレイテッド |
ニコチンアミドリボシド及びプテロスチルベン組成物及び神経変性障害の治療方法
|
|
NZ803738A
(en)
|
2016-11-11 |
2024-05-31 |
Chromadex Inc |
Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
|
|
US11071747B2
(en)
|
2016-11-29 |
2021-07-27 |
University Of Iowa Research Foundation |
Use of NAD precursors for breast enhancement
|
|
EP3554285A4
(en)
|
2016-11-29 |
2021-01-20 |
University of Iowa Research Foundation |
USE OF NAD PRECURSORS TO IMPROVE THE HEALTH OF MOTHER AND / OR OFFspring
|
|
US20190328761A1
(en)
|
2016-12-21 |
2019-10-31 |
Newsouth Innovations Pty Limited |
Methods for enhancing vascular density
|
|
EP3568488A4
(en)
*
|
2017-01-13 |
2020-09-23 |
The Regents of The University of Colorado, A Body Corporate |
METHODS OF TREATMENT OF HYPERTENSION AND ARTERIAL RIGIDITY
|
|
US11129843B2
(en)
|
2017-04-24 |
2021-09-28 |
Elysium Health, Inc. |
Treating and preventing kidney damage
|
|
EP3624808A4
(en)
*
|
2017-05-18 |
2021-03-03 |
Elysium Health, Inc. |
PROCEDURES AND COMPOSITIONS FOR IMPROVED SLEEP
|
|
US11286274B2
(en)
|
2017-06-19 |
2022-03-29 |
Mitopower Llc |
Nicotinamide riboside derivatives and their uses
|
|
WO2018236747A1
(en)
*
|
2017-06-21 |
2018-12-27 |
Yale University |
COMPOUNDS AND COMPOSITIONS FOR EXTENDING THE DURATION OF A SUBJECT
|
|
JP2020526511A
(ja)
*
|
2017-06-30 |
2020-08-31 |
エリジウム・ヘルス・インコーポレイテッド |
ニコチンアミドリボシドの合成方法
|
|
KR101990681B1
(ko)
*
|
2017-07-05 |
2019-06-18 |
가천대학교 산학협력단 |
편두통 진단용 바이오마커 및 상기 바이오마커를 이용한 편두통 진단방법
|
|
KR101982923B1
(ko)
*
|
2017-07-05 |
2019-05-27 |
가천대학교 산학협력단 |
편두통 진단용 바이오마커 및 상기 바이오마커를 이용한 편두통 진단방법
|
|
EP3727400A4
(en)
*
|
2017-12-22 |
2021-10-20 |
Elysium Health, Inc. |
CRYSTALLINE FORMS OF NICOTINAMIDE RIBOSIDE CHLORIDE
|
|
WO2019133815A1
(en)
|
2017-12-28 |
2019-07-04 |
Kansas State University Research Foundation |
Nicotinamide riboside treatments of domesticated meat animals
|
|
WO2019152416A1
(en)
|
2018-01-30 |
2019-08-08 |
Metro International Biotech, Llc |
Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof
|
|
CN110283221A
(zh)
*
|
2018-03-19 |
2019-09-27 |
药源药物化学（上海）有限公司 |
杂环化合物的制备和纯化方法
|
|
WO2019209840A1
(en)
*
|
2018-04-23 |
2019-10-31 |
Elysium Health, Inc. |
Methods and compositions for treating rheumatoid arthritis
|
|
CN110452277A
(zh)
*
|
2018-05-07 |
2019-11-15 |
明特奇点医疗科技(成都)有限公司 |
一种烟酰胺核糖的制备方法
|
|
CN112135833A
(zh)
*
|
2018-05-18 |
2020-12-25 |
弗·哈夫曼-拉罗切有限公司 |
(硫代)烟酰胺呋喃核糖苷盐及其组合物、制备方法和用途
|
|
BR112020023132A2
(pt)
*
|
2018-06-21 |
2021-02-09 |
Société des Produits Nestlé S.A. |
composições e métodos que usam um precursor de nicotinamida adenina dinucleotídeo (nad+) e pelo menos uma cetona ou um precursor de cetona
|
|
CN108774278A
(zh)
*
|
2018-09-10 |
2018-11-09 |
张洪喜 |
一种制备尼克酰胺核苷盐的方法
|
|
US20210393621A1
(en)
|
2018-10-26 |
2021-12-23 |
The Research Foundation For The State University Of New York |
Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
|
|
WO2020131578A2
(en)
|
2018-12-17 |
2020-06-25 |
Mitopower Llc |
Nicotinyl riboside compounds and their uses
|
|
US10618927B1
(en)
|
2019-03-22 |
2020-04-14 |
Metro International Biotech, Llc |
Compositions and methods for modulation of nicotinamide adenine dinucleotide
|
|
US11939348B2
(en)
|
2019-03-22 |
2024-03-26 |
Metro International Biotech, Llc |
Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide
|
|
US20200397807A1
(en)
|
2019-06-18 |
2020-12-24 |
MitoPower, LLC |
Nicotinyl riboside compounds and their uses
|
|
JP7675061B2
(ja)
|
2019-07-19 |
2025-05-12 |
バイオシント アクチェンゲゼルシャフト |
ニコチンアミドリボフラノシド塩の製造方法、ニコチンアミドリボフラノシド塩自体、およびその使用
|
|
PH12022551051A1
(en)
*
|
2019-11-01 |
2023-05-03 |
Celagenex Res India Pvt Ltd |
Synergistic nutritional compositions for treating cerebrovascular diseases
|
|
WO2021180739A1
(en)
*
|
2020-03-09 |
2021-09-16 |
Société des Produits Nestlé S.A. |
Compositions and methods containing reduced nicotinamide riboside for prevention and treatment of viral and bacterial infections
|
|
CN111454311B
(zh)
|
2020-04-03 |
2021-10-19 |
深圳市迪克曼科技开发有限公司 |
烟酰胺核糖的有机酸盐及其组合物与制备方法
|
|
JP7213603B2
(ja)
*
|
2020-06-19 |
2023-01-27 |
ボンタック バイオエンジニアリング（シェンゼン） カンパニー リミテッド |
ニコチンアミドを原料としてニコチンアミドモノヌクレオチドを調製する方法
|
|
CN111808156A
(zh)
*
|
2020-07-15 |
2020-10-23 |
许昌远志生物科技有限公司 |
一种β-烟酰胺核糖氯化物的晶型1A、晶型1B及其制备方法
|
|
US20230263817A1
(en)
*
|
2020-08-28 |
2023-08-24 |
University Of Washington |
High dose nicotinamide adenine dinucleotide (nad) precursor regimens for reduction of inflammation in human patients with preexisting inflammation
|
|
CN112028954B
(zh)
*
|
2020-09-14 |
2022-04-29 |
浩宇康宁健康科技（湖北）有限公司 |
烟酰胺核糖的制备方法
|
|
US20240059727A1
(en)
*
|
2021-01-19 |
2024-02-22 |
Biosynth Ag |
Method of making nicotinamide ribofuranoside salts by salt metathesis, the crystalline form of its tosylate salt and the co-crystallized form of its chloride:iodide salt
|
|
CA3206155A1
(en)
*
|
2021-01-29 |
2022-08-04 |
ChromaDex Inc. |
Ethyl cellulose based coatings for microencapsulation of nicotinamide riboside and other nicotinyl riboside compounds
|
|
CA3219033A1
(en)
|
2021-05-27 |
2022-12-01 |
Metro International Biotech, Llc |
Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use
|
|
CN113943333B
(zh)
*
|
2021-10-09 |
2023-07-14 |
广东生命源科技有限公司 |
一种氢化烟酰胺核糖的制备方法及应用
|
|
CN118176006A
(zh)
*
|
2021-10-27 |
2024-06-11 |
益力舒健康公司 |
治疗更年期综合征的方法
|
|
WO2023147161A2
(en)
*
|
2022-01-31 |
2023-08-03 |
New Frontier Bio, Inc. |
Nicotinate and nicotinamide riboside-based compounds and derivatives thereof
|
|
CN114577935B
(zh)
*
|
2022-03-03 |
2024-07-23 |
中科谱研（北京）科技有限公司 |
一种胶囊中烟酰胺核糖氯化物的分离检测方法
|
|
EP4493572A4
(en)
*
|
2022-03-15 |
2025-11-19 |
Chromadex Inc |
PROCESSES FOR THE PRODUCTION OF BETA NICOTINAMIDE TRIACETATE RIBOSIDE CRYSTALLINE
|
|
CN116621898A
(zh)
*
|
2022-04-13 |
2023-08-22 |
深圳市迪克曼科技开发有限公司 |
烟酰胺核糖的有机酸盐及其结晶形态、制备方法与用途
|
|
CN115287278B
(zh)
*
|
2022-06-17 |
2023-11-10 |
武汉真福医药股份有限公司 |
一种枯草芽孢杆菌纤溶酶及其制备方法和抗氧化溶血栓组合物
|
|
WO2024160239A1
(zh)
|
2023-02-01 |
2024-08-08 |
博迪贺康(北京)生物技术有限公司 |
一种化合物及其应用
|
|
CN116655528B
(zh)
*
|
2023-04-28 |
2025-12-02 |
宁波百思佳医药科技有限公司 |
一种氯化1-甲基烟酰铵的制备方法
|
|
EP4727544A2
(en)
|
2023-06-14 |
2026-04-22 |
Chromadex Inc. |
Nicotinamide riboside and derivatives thereof in intravenous formulations and methods of use thereof
|